Brief: Firebrick Pharma Says Nasal Spray Now Allowed In Canada
09/05/2023 24:32
May 9 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* NASODINE NASAL SPRAY AS A TREATMENT AND PREVENTATIVE FOR
COMMON
COLD HAS NOW BEEN ALLOWED IN CANADA
Source text for Eikon: ID:nASX3vT1nq
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement